Ruth Steer

Following my journey through academia, I entered the world of scientific writing and never looked back. After several years of working as a medical writer – where I developed a wide range of skills in healthcare publications and communications – I took the opportunity to stretch my creative and journalistic muscles and joined Texere Publishing. Working as Editor on The Ophthalmologist allows me to nurture my skills in scientific writing – and explore the dynamic world of ophthalmology – all within an innovative and exciting company.

Content by Ruth Steer:

 Research Field Immunology

Not Immune to Damage

| Ruth Steer

Could activated T cells play a major role in driving neurodegeneration in glaucoma?
Research Field Cell & gene therapy

The Best Treatment

| Ruth Steer

Is gene therapy the answer to an untreatable form of macular degeneration?
Disease Area Analytical science

The Biomarker Breakdown

| Ruth Steer

Could macular degeneration be diagnosed through blood plasma analysis?
Outside the Lab Imaging

“May I Enjoy Life and Art”

| Ruth Steer

Research shows that art training can improve ophthalmologists’ observational skills.
Tools & Techniques Cell & gene therapy

Small(er) Sequence, Big(ger) Promise

| Ruth Steer

CRISPR gene editing with a newly characterized orthologue may bring the approach closer to the clinic.
Research Field Imaging

“Miami, We Have a Problem”

| Ruth Steer

The first quantitative evidence for CSF in spaceflight-induced ocular changes are discovered
Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register

October Issue of The Translational Scientist